Recro Pharma, Inc. (NASDAQ:REPH) has scheduled a conference call for 10th August 2020 at 8:00 AM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.recropharma.com
Earnings Expectation
Recro Pharma, Inc. is reporting second quarter earnings results on Monday 10th August 2020, before market open. The consensus estimates from Thomson Reuters are loss of $ 0.16 per share. For the full year, analysts predict revenues of $ 81.11 million, while looking forward to loss of $ 0.55 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 80.00 million ~ $ 85.00 million
Click Here For More Historical Outlooks Of Recro Pharma, Inc.
Recro Pharma, Inc. operates as a specialty pharmaceutical company. It operates through two divisions, an Acute Care, and Contract Development and Manufacturing (CDMO).
